BETHANY CHAPPELL: Open Payments
NPI 1174308472 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,538 in 111 payments from 23 companies in 2025. Trend: 2023 $407 · 2024 $3,059 · 2025 $2,538
Food & beverage: $2,538
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $353 |
| UCB, Inc. | 11 | $260 |
| Teva Pharmaceuticals USA, Inc. | 9 | $217 |
| ABBVIE INC. | 18 | $205 |
| Novartis Pharmaceuticals Corporation | 8 | $184 |
| Lilly USA, LLC | 8 | $180 |
| Eisai Inc. | 4 | $179 |
| MDD US Operations, LLC | 2 | $153 |
| Alexion Pharmaceuticals, Inc. | 5 | $122 |
| Axsome Therapeutics, Inc. | 4 | $97 |
Products named: NURTEC ODT, AUSTEDO XR, KESIMPTA, Leqembi, KISUNLA, ULTOMIRIS, UBRELVY, Nayzilam.
Industry payments across FL — which companies pay providers there.
